Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy

Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved targeted agent in ovarian cancer. Anti-angiogenic agents mainly include agents target VEGF/VEGFR pathway, such as bevaciz...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Chengwen, Yuan, Mingyuan, Bu, Hualei, Jin, Chengjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019437/
https://www.ncbi.nlm.nih.gov/pubmed/35466318
http://dx.doi.org/10.1155/2022/4880355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019437/
https://www.ncbi.nlm.nih.gov/pubmed/35466318
http://dx.doi.org/10.1155/2022/4880355

Ejemplares similares